Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in HS
NCT07756346Phase 2Not yet recruiting
- Sponsor
- University of Massachusetts
- Start
- Oct 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in hidradenitis suppurativa (HS), sponsored by University of Massachusetts. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT07756346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07756346.